SMS PHARMACEUTICALS
Back to Balance Sheet
|
SMS PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹43 Cr | ₹41 Cr | ₹40 Cr | ₹54 Cr | ₹40 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SMS PHARMACEUTICALS ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹43 Cr |
Mar2023 | ₹41 Cr |
Mar2022 | ₹40 Cr |
Mar2021 | ₹54 Cr |
Mar2020 | ₹40 Cr |
How is Deferred Tax Assets / Liabilities of SMS PHARMACEUTICALS Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹43 Cr | 4.34 | |
Mar2023 | ₹41 Cr | 3.71 | |
Mar2022 | ₹40 Cr | -26.56 | |
Mar2021 | ₹54 Cr | 35.50 | |
Mar2020 | ₹40 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of SMS PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SMS PHARMACEUTICALS | ₹1,571.6 Cr | -12.7% | -14.7% | 29.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,259.0 Cr | 0.5% | -3.4% | 13.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,917.0 Cr | -2.2% | 0.3% | 58.8% | Stock Analytics | |
CIPLA | ₹119,705.0 Cr | 2.2% | 3.9% | 2.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,953.9 Cr | -1.5% | -7% | -5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹91,889.3 Cr | -2.3% | -7.4% | 3.7% | Stock Analytics |
SMS PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SMS PHARMACEUTICALS | -12.7% |
-14.7% |
29.5% |
SENSEX | -0.4% |
-1.4% |
5.4% |
You may also like the below Video Courses